A recent study from the United Nations Population Fund (UNFPA) and its partners found that women and girls of African descent living in the Americas are up to three times more likely to die from preventable maternal death causes. So it is no surprise that UNFPA’s Executive Director of Programs, Diene Keita, is calling attention to this challenge.

Each day, almost 800 women die from preventable causes related to pregnancy and childbirth. A maternal death occurs every two minutes. Maternal mortality is defined as the death of a woman from complications of pregnancy or childbirth that occur during the pregnancy or within 6 weeks after the pregnancy ends.*

Two years ago, the World Health Organization (WHO) declared a public health emergency after a multi-country outbreak of mpox (formerly known as monkeypox). Now, in the summer of 2024, mpox is on the rise again. On August 14, The WHO declared a new public health emergency due to a recent outbreak in the Democratic Republic of the Congo (DRC) and other African countries.

We’re often told that we’re living during a population crisis, a time of simultaneous concerns born of too many people to sustain necessary resources for a healthy planet, and too few working-age people to support a healthy economy. Population dynamics and trends are key to national and international security and contribute to the overall wellbeing of a society. Fertility, along with mortality and migration, is central to population and its importance to demographers, policymakers, economists, and a country’s development is without question. But focusing on population trends without considering the experiences of the billions of individuals who make up those trends—each with a unique life course, personal aspirations, and individual potential—establishes an unhealthy and dangerous tension that can strip women of their rights and leave them socially disenfranchised.

Gambian lawmakers voted on July 15, 2024, to maintain the nine-year old ban on female genital cutting (FGC). Also known as female genital mutilation (FGM), female genital cutting is defined by the World Health Organization as “all procedures that involve partial or total removal of the external female genitalia, or other injury to the female genital organs for non-medical reasons.” The negative health outcomes of FGC can include severe pain, infections, sexual health problems, and obstetric complications.

Ongoing fighting in Sudan has led to a devastating humanitarian crisis that United Nations Humanitarian and Emergency Relief Chief Martin Griffiths calls “one of the worst humanitarian nightmares in recent history.”  

Among the millions of people harmed by the fighting are countless pregnant people and new mothers, who face direct and indirect threats to their health and lives in the country’s renewed conflict. Sudan was already suffering from a maternal mortality crisis prior to the onset of its latest civil war. Before the most recent round of bloodshed, Sudan’s maternal mortality rate stood at 270 deaths per 100,000 live births in 2020 – higher than the global average of 223 deaths. And as this crisis worsens, it is imperative to call attention to what is occurring there.  

Last month, the biopharmaceutical company Gilead shared groundbreaking results from a recent clinical trial (PURPOSE1) for long-acting injectable HIV prevention. The twice-yearly injectable drug, lenacapavir, provided total protection from HIV for a test group of 2,134 women in Uganda and South Africa. While lenacapavir has been used to treat multi-drug resistant HIV since 2022, this trial marks the first usage as pre-exposure prophylaxis (PrEP). PrEP is one tool to prevent the virus, and refers to anti-retroviral medication taken by people who do not have HIV to reduce the risk of contracting it through sexual transmission or injection drug use. These new findings offer immense promise for the future of PrEP as a global tactic to protect young women from contracting HIV.